Safety and Immunogenicity Study of SCB-1019T in Children

Stopped The study was terminated during the EC submission process prior to the enrolment

Conditions

• RSV Infection

Interventions

• BIOLOGICAL: low dose SCB-1019T
• BIOLOGICAL: adjuvanted low dose SCB-1019T
• BIOLOGICAL: high dose SCB-1019T
• BIOLOGICAL: adjuvanted high dose SCB-1019T
• OTHER: Placebo

Sponsor

Clover Biopharmaceuticals AUS Pty